Tumor burden and serum level of soluble CD25, CD8, CD23, CD54 and CD44 in non-Hodgkin's lymphoma

Pérez Encinas, Manuel Mateo; Villamayor Álvarez, Mercedes; Campos Pena, Alfredo; González Pérez, Marta Sonia; Bello López, José Luis
Thumbnail
Estatísticas
Estatísticas
Identificadores
Identificadores
URI: http://hdl.handle.net/20.500.11940/22542
PMID: 9793264
ISSN: 0390-6078
Rexistro completo
Servizos
Servizos
RISMendeleyLinksolver
Visualización ou descarga de ficheiros
Visualización ou descarga de ficheiros
Data de publicación
1998
Título da revista
Haematologica
Tipo de contido
Artigo
DeCS
pronóstico | linfoma | sensibilidad y especificidad | linfoma no Hodgkin | receptores de IgE | molécula 1 de adhesión intercelular | antígenos CD | receptores de interleucina-2
MeSH
Prognosis | Lymphoma | Antigens, CD | Intercellular Adhesion Molecule-1 | Lymphoma, Non-Hodgkin | Receptors, Interleukin-2 | Sensitivity and Specificity | Receptors, IgE
CIE
Linfoma de células B, sin otra especificación
Resumo
[EN] We studied the value of soluble CD25, CD8, CD23, CD54 and CD44 serum levels as tumor burden markers in lymphoma. Soluble CD25 compared with the others sCD and the usual serum factors (albumin, lactate dehydrogenase, beta 2-microglobulin, uric acid and C-reactive protein), showed the strongest correlation with the Ann Arbor stage and the number of affected localizations. sCD25 level is the most sensitive serum marker for tumor burden in lymphoma.
Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)
A non ser que se indique outra cousa, a licenza do ítem descríbese comoAttribution-NonCommercial 4.0 International (CC BY-NC 4.0)